Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.08%163.64B | 3.71%681.76B | 4.57%161.9B | 4.67%657.4B | 5.71%161.94B | 3.78%176.92B | 5.58%163.73B | 3.66%154.81B | 21.15%628.09B | 4.11%153.19B |
| Cost of revenue | 1.93%90.42B | 1.25%374.4B | 0.75%88.71B | 1.97%369.79B | 2.53%90.17B | 1.36%98.13B | 3.73%93.44B | 0.28%88.05B | 20.97%362.64B | 0.86%87.94B |
| Gross profit | 0.05%73.22B | 6.87%307.36B | 9.62%73.18B | 8.35%287.61B | 9.98%71.77B | 6.97%78.79B | 8.15%70.29B | 8.47%66.76B | 21.39%265.45B | 8.84%65.26B |
| Operating expense | 5.95%67.72B | 4.37%272.84B | 3.09%63.92B | 2.90%261.42B | 6.98%67.77B | 1.85%66.5B | 0.95%65.15B | 1.84%62B | 16.57%254.06B | 5.69%63.35B |
| Staff costs | ---- | 3.20%80.7B | ---- | 1.73%78.2B | ---- | ---- | ---- | ---- | 13.79%76.87B | ---- |
| Rent and land expenses | ---- | 1.55%49.45B | ---- | 2.47%48.7B | ---- | ---- | ---- | ---- | 17.43%47.52B | ---- |
| Other operating expenses | ---- | 6.06%142.69B | ---- | 3.75%134.53B | ---- | ---- | ---- | ---- | 17.97%129.67B | ---- |
| Operating profit | -40.59%5.51B | 31.81%34.52B | 94.75%9.27B | 129.95%26.19B | 109.85%4B | 46.86%12.29B | 1,042.00%5.14B | 616.57%4.76B | 1,436.98%11.39B | 8,985.71%1.91B |
| Net non-operating interest income (expenses) | 1.29%-153M | -7.85%-618M | -6.16%-155M | -36.10%-573M | -39.60%-141M | -34.29%-141M | -31.82%-145M | -39.05%-146M | -3.44%-421M | -17.44%-101M |
| Non-operating interest income | -15.25%50M | -22.19%242M | -23.38%59M | -42.51%311M | -39.37%77M | -42.34%79M | -43.07%78M | -45.00%77M | 1.50%541M | -13.01%127M |
| Non-operating interest expense | -5.14%203M | -2.71%860M | -4.04%214M | -8.11%884M | -4.39%218M | -9.09%220M | -9.72%223M | -8.98%223M | 2.34%962M | -1.72%228M |
| Net investment income | -56.93%525M | 46.82%1.78B | 66.53%1.22B | -39.12%1.21B | 77.73%-104M | 2.77%483M | -83.87%100M | -46.41%732M | -23.26%1.99B | -187.45%-467M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 14.55B | 14.23B | 0 | 0 | 0 | -42.56%3.5B | -21M | ||
| Income from associates and other participating interests | -36.70%119M | 19.88%784M | 1,144.44%188M | 332.74%654M | 873.68%185M | 644.00%408M | 171.17%79M | 84.21%-18M | 68.81%-281M | 107.51%19M |
| Special income (charges) | -96.98%319M | 143.15%2.03B | 2,246.22%10.56B | -184.38%-4.69B | -307.60%-7.08B | 1,536.77%2.23B | -110.49%-293M | 192.98%450M | -32.67%5.56B | 1,993.89%3.41B |
| Less:Restructuring and mergern&acquisition | --0 | ---7.98B | ---7.98B | --0 | ---- | ---- | ---- | ---- | 147.67%798M | ---- |
| Less:Other special charges | 87.61%-319M | 177.87%1.95B | -472.00%-2.57B | 75.55%-2.5B | 100.58%47M | -1,643.87%-2.39B | 110.49%293M | -192.98%-450M | -20.89%-10.24B | -586.69%-8.08B |
| Less:Write off | ---- | -44.27%4.01B | ---- | 85.61%7.2B | 81.33%7.03B | --166M | ---- | ---- | 106.11%3.88B | 115.27%3.88B |
| Other non-operating income (expenses) | -108.18%-48M | -242.17%-1.7B | 325.77%587M | 14.58%-498M | -3.65%-199M | 17.48%-118M | 179.80%79M | -74.50%-260M | 25.73%-583M | 22.27%-192M |
| Income before tax | -82.00%6.27B | 130.29%51.33B | 531.36%34.83B | 5.41%22.29B | -173.20%-3.33B | 27.56%15.15B | 39.87%4.96B | 369.45%5.52B | 35.67%21.15B | 2,237.09%4.55B |
| Income tax | -75.90%1.83B | 950.79%15.65B | 378.92%7.61B | -158.44%-1.84B | -483.28%-7.71B | 9.20%3.19B | -2.59%1.09B | 273.00%1.59B | -43.46%3.15B | -148.87%-1.32B |
| Net income | -83.72%4.43B | 47.88%35.68B | 593.05%27.22B | 34.06%24.13B | -25.43%4.38B | 33.57%11.96B | 59.49%3.87B | 424.30%3.93B | 79.62%18B | 301.37%5.87B |
| Net income continuous operations | -83.71%4.43B | 47.89%35.68B | 593.05%27.22B | 34.05%24.13B | -25.45%4.38B | 33.56%11.96B | 59.49%3.87B | 424.30%3.93B | 79.63%18B | 301.30%5.87B |
| Noncontrolling interests | -39.81%452M | -62.19%841M | 35.32%751M | 37.62%2.22B | -44.77%248M | -39.03%478M | 230.88%943M | 466.33%555M | 991.89%1.62B | 449M |
| Net income attributable to the company | -84.96%3.98B | 59.06%34.84B | 685.05%26.46B | 33.71%21.91B | -23.82%4.13B | 40.54%11.48B | 36.65%2.92B | 417.82%3.37B | 65.94%16.38B | 277.00%5.43B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -84.96%3.98B | 59.06%34.84B | 685.05%26.46B | 33.71%21.91B | -23.82%4.13B | 40.54%11.48B | 36.65%2.92B | 417.82%3.37B | 65.94%16.38B | 277.00%5.43B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -86.49%32.89 | 55.68%295.51 | 736.04%243.37 | 39.73%189.82 | -21.86%35.88 | 47.82%99.47 | 46.17%25.36 | 450.28%29.11 | 70.15%135.85 | 285.76%45.92 |
| Diluted earnings per share | -86.38%32.6 | 53.78%289.19 | 728.53%239.28 | 39.49%188.05 | -22.28%35.41 | 47.70%98.62 | 45.91%25.14 | 450.10%28.88 | 70.09%134.81 | 284.30%45.56 |
| Dividend per share | 0 | 68.00%42 | 0 | 0.00%25 | 0.00%12.5 | 0 | 0.00%12.5 | 0 | 0.00%25 | 0.00%12.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |